ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PRTC PureTech Health PLC

28.79
0.00 (0.00%)
Pre Market
Last Updated: 06:37:54
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
PureTech Health PLC PRTC NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 28.79 06:37:54
Open Price Low Price High Price Close Price Prev Close
28.79
more quote information »

Recent News

Date Time Source Heading
6/18/202407:05BWPureTech Founded Entity Seaport Therapeutics Appoints..
6/13/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/13/202413:15BWPureTech Health: Results of Annual General Meeting
6/06/202416:39EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
6/06/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/06/202412:38BWPureTech Health: Result of General Meeting
6/04/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/04/202407:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
5/30/202408:05EDGAR2Form SC 13D/A - General statement of acquisition of..
5/29/202416:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/29/202408:09BWPureTech Founded Entity Akili Interactive and Virtual..
5/23/202407:00BWPureTech to Present at the Jefferies Global Healthcare..
5/21/202407:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
5/20/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/20/202407:03EDGAR2Form SC TO-I - Tender offer statement by Issuer
5/20/202402:00BWPureTech Health: Launch of Proposed $100 Million Tender..
5/09/202407:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
5/07/202407:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
4/25/202405:22BWPureTech Announces Annual Results for Year Ended December..
4/18/202402:00BWPureTech Health: Notice of Results
4/16/202407:00BWPureTech Announces Completion of Enrollment in Phase 2b..
4/11/202407:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
4/09/202402:00BWPureTech Launches Seaport Therapeutics with $100 Million..
3/19/202403:00BWPureTech Proposes $100 Million Capital Return
3/18/202409:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
3/13/202407:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
2/27/202407:00BWPureTech to Present at Two Upcoming Investor Conferences
2/27/202402:00BWPureTech Founded Entity Akili Announces Positive Results..
1/04/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202407:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
12/22/202309:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
12/20/202302:00BWPureTech Year End Update and Outlook for 2024
12/07/202306:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
11/29/202310:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
11/17/202302:00BWPureTech Founded Entity Karuna Therapeutics Announces..
11/14/202302:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
11/02/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/17/202302:00BWPureTech to Present at Two Upcoming Investor Conferences
10/11/202307:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
10/04/202307:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
9/28/202307:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
9/27/202302:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
9/06/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/202306:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/202302:00BWPureTech Health plc – Half-Year Report
8/22/202302:00BWPureTech Health: Notice of Half-Yearly Results
8/02/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202307:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..
7/06/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/21/202307:00BWPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral..